Spectral AI Investor Relations Material

Spectral AI Inc., also known as Spectral AI, operates as an artificial intelligence company focused on medical diagnostics. The company specializes in predictive diagnostics for wound care, particularly for patients with burns and diabetic foot ulcers. Its primary product, the DeepView® Wound Imaging System, utilizes multispectral imaging and artificial intelligence to provide clinicians with immediate and objective assessments of a wound’s healing potential. This technology aids in making faster and more accurate treatment decisions. Spectral AI aims to expand its technology platform into other clinical indications beyond its current focus areas. The company is headquartered in Dallas, Texas, and its shares are listed on the Nasdaq.